In January 2013, Gail Page founded Vineyard Investment Advisors. Prior to this venture, Ms. Page served as the President / CEO of Vermillion, Inc. from Jan 2006 through December 2012. She was a member of the board from 2006 thru 2012 and served as chairperson from 2010 to 2011. Vermillion is a healthcare company focused on developing and commercializing novel diagnostic blood tests. Under her leadership the company successfully raised more than $100 million in funding and developed and commercially launched the first FDA-cleared blood test to help diagnose ovarian cancer. Ms. Page is a member of the American Association of Clinical Chemistry, the Central Texas Angel Network, the Greater Austin Chamber, and the National Association of Corporate Directors. Most recently, she has joined Consortia Health as Partner and Executive Chair, also headquartered in Austin. Ms. Page earned her degrees from Santa Fe Community College and the University of Florida. In 2003, she completed an executive management program at the Kellogg School in Chicago.
© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.